3

MAIN DOCUMENT DESCRIPTION

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: May 27, 2004
Period of Report: May 27, 2004
Accession Number: 0001209191-04-028447

View Document ↗ View on SEC.gov ↗